The effect of elimination treatment with benzyl benzoate was examined in 30 adults with asthma caused by sensitivity to house dust mites. The patients were randomised into a control and an active group, who treated their mattresses with benzyl benzoate (Acarosan®). The study lasted 12 months and the effect of the treatment was monitored by monthly dust sampling, analyzed for major allergens fromDermatophagoides pteronyssinus andfarinae by the ELISA method and for guanine by the Acarex® method. The clinical effect was assessed by measuring lung function, daily peak flows, symptoms and medicine consumption as well as skin prick tests, and specific IgE to mite allergens. For both groups, a significant decrease was observed in house dust mite allergens, but there was no significant difference between the groups. No considerable differences were observed in clinical parameters within or between the groups. A good correlation was observed between ELISA and Acarex®. but the latter showed a major variation in the different classes. In conclusion. treatment of mattresses with benzyl benzoate had no effect in a group of patients with asthma due to house dust mite allergy. Regular vacuum cleaning of the bed may reduce house dust mite allergen exposure.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Aas, K., Backman, A., Belin, L. and Weeke, B. (1978) Standardization of allergen extracts with appropriate methods. Allergy 33, 130–137.
Ehnert, B., Lau-Schadendorf, S., Weber, A., Buettner, P., Schou, C. and Wahn, U. (1992) Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J. Allergy Clin. Immunol. 90, 135–138.
Harving, H., Korsgaard, J. and Dahl, R. (1988) Mechanical ventilation in dwellings as preventive measure in mite-asthma (Abstract). Allergy Proc. 9, 283.
Hayden, M.L., Rose, G., Diduch, K.B. et al. (1992) Benzyl benzoate moist powder: investigation of acaricidal activity in cultures and reduction of dust mite allergens in carpets. J. Allergy Clin. Immunol. 89, 536–545.
Kniest, F.M., Young, E., Van Praag, M.C.G., Vos, H., Kort, H.S.M., Koers, W.J., De Matt-Bleeker, F. and Van Bronswijk, J.E.M.H. (1991) Clinical evaluation of a double-blind dust-mite avoidance trial with mite-allergic rhinitic patients. Clin. Exp. Allergy 21, 39–47.
Korsgaard, J. (1983a) Mite-asthma and residency — a case control study on the impact of exposure to house dust mites in dwellings. Am. Rev. Respir. Dis. 128, 231–235.
Korsgaard, J. (1983b) House dust mites and absolute indoor humidity. Allergy 38, 85–92.
Korsgaard, J. and Iversen, M. (1991) Epidemiology of house dust mite allergy. Allergy 46 (Suppl. II), 14–18.
Landegren, J., Borglund, E. and Storgards, K. (1979) Treatment of scabies with disulfiram and benzyl benzoate emulsion: a controlled study. Acta Derm. Venereol.-Stock. 59(3), 274–276.
Le Mao, J., Pauli, G., Tekaia, F., Hoyet, C., Bischoff, E. and David, B. (1989) Guanine content andDermatophagoides pteronyssinus allergens in house dust samples. J. Allergy Clin. Immunol. 83, 926–933.
Lind. P. (1986) Enzyme-linked immunosorbent assay for determination of major excrement allergens of house dust mite speciesD. pteronyssinus, D. farinae andD. microceras. Allergy 41, 442–451.
Maunsell. K., Wraith, D.G. and Cunnington, A.M. (1968) Mites and house dust allergy in bronchial asthma. Lancet 1, 1267–1270.
Mosbech, H., Heinig, J.H. and Johansen, N. (1988) New equipment for standardized dust sampling (Abstract). Allergy 43 (Suppl. 7), 63.
About this article
Cite this article
Olsen, O.T., Jacobsen, L. & Svendsen, U.G. Effectiveness of benzyl benzoate in elimination of house dust mites. Aerobiologia 12, 3–8 (1996). https://doi.org/10.1007/BF02248117
- House dust mites
- Benzyl benzoate
- Acarosan®: Aerobiology